logo-loader
RNS
Instem PLC

Instem plc - Completion of the Acquisition of Leadscope

RNS Number : 6225T
Instem plc
15 November 2019
 

 

 

Instem plc

 

("Instem")

 

Completion of the Acquisition of Leadscope, Inc. ("Leadscope")

 

 

Instem (AIM: INS.L), a leading provider of IT solutions to the global life sciences market, confirms that further to its announcement at 7.00 a.m. today, it has now completed the acquisition of Leadscope.

 

For further information, please contact:

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

 

Nigel Goldsmith, CFO

 

 

 

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Richard Lindley

Rachel Hayes

 

 

 

Walbrook Financial PR

+44 (0) 20 7933 8000

Nick Rome

instem@walbrookpr.com

Tom Cooper

 

 

 

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

 

Instem solutions are in use by over 500 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

 

Instem products and services now address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.

 

To learn more about Instem solutions and its mission, please visit www.instem.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURFFMFDIFUSESF
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

SEND platform the star first-half performer for Instem PLC

Phil Reason, chief executive of Instem Plc (LON:INS), caught up with Proactive to discuss their first-half 2018 trading update. He says trading's been in line with expectations with the standout performer being their SEND platform where the value of contracts won so far this year has...

on 24/7/18

2 min read